Skip to main content
Premium Trial:

Request an Annual Quote

Affiris Taps Probiogen for Vaccine Targets Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vaccine developer Affiris will use Probiogen's Human Artificial Lymph Node Technology (HuALN) as an analytical tool to find targets for its Affitome vaccination project, Affiris said today.

Under the agreement, Affiris will evaluate the HuALN technology as a human organoid model to study drug-related effects in the context of the human immune system in order to select possible vaccine candidates that it aims to take into clinical trials. HuALN's method of harvesting cells after bioreactor operation allows for functional testing and analysis of surface markers by flow cytometry, the firms said.

Vienna, Austria-based Affiris is developing tailor-made peptide vaccines against Alzheimer's disease, atherosclerosis, Parkinson's disease, hypertension, and four other conditions. It currently has two potential products for Alzheimer's that have completed phase I clinical trials.

"We have been looking for a system like the Human Artificial Lymph Node for quite a long time and are excited by the possibilities the system offers to test our peptide vaccine candidates," Affiris CEO Walter Schmidt said in a statement.

Financial terms of the agreement were not released.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.